In today’s recent session, 0.53 million shares of the NeuroSense Therapeutics Ltd (NASDAQ:NRSN) have been traded, and its beta is 1.36. Most recently the company’s share price was $0.92, and it changed around -$0.1 or -9.94% from the last close, which brings the market valuation of the company to $19.02M. NRSN at last check was trading at a discount to its 52-week high of $2.33, offering almost -153.26% off that amount. The share price’s 52-week low was $0.51, which indicates that the recent value has risen by an impressive 44.57% since then. We note from NeuroSense Therapeutics Ltd’s average daily trading volume that its 10-day average is 0.29 million shares, with the 3-month average coming to 192.60K.
NeuroSense Therapeutics Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended NRSN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. NeuroSense Therapeutics Ltd is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
Instantly NRSN has been showing red trend so far today with a performance of -9.94% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.1180 on recent trading dayincreased the stock’s daily price by 17.71%. The company’s shares are currently up 17.02% year-to-date, but still down -14.15% over the last five days. On the other hand, NeuroSense Therapeutics Ltd (NASDAQ:NRSN) is -30.41% down in the 30-day period. We can see from the shorts that 0.32 million shares have been sold at a short interest cover period of 2.01 day(s).
MEITAV INVESTMENT HOUSE LTD, with 0.2597% or 40000.0 shares worth $44800.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 11.96 shares worth $11244.0, making up 0.05% of all outstanding shares.
